Genetic Analysis Workshop 19: methods and strategies for analyzing human sequence and gene expression data in extended families and unrelated individuals by Engelman, Corinne D. et al.
BMC ProceedingsThe Author(s) BMC Proceedings 2016, 10(Suppl 7):19DOI 10.1186/s12919-016-0007-zPROCEEDINGS Open AccessGenetic Analysis Workshop 19: methods
and strategies for analyzing human
sequence and gene expression data in
extended families and unrelated individuals
Corinne D. Engelman1*, Celia M. T. Greenwood2, Julia N. Bailey3, Rita M. Cantor4, Jack W. Kent Jr5, Inke R. König6,
Justo Lorenzo Bermejo7, Phillip E. Melton8, Stephanie A. Santorico9, Arne Schillert10, Ellen M. Wijsman11,
Jean W. MacCluer5 and Laura Almasy12From Genetic Analysis Workshop 19
Vienna, Austria. 24-26 August 2014Abstract
Genetic Analysis Workshop 19 provided a platform for developing and evaluating statistical methods to analyze
whole-genome sequence and gene expression data from a pedigree-based sample, as well as whole-exome
sequence data from a large cohort of unrelated individuals. In this article we present an overview of the data sets,
the GAW experience, and summaries of the contributions arranged into nine methodological themes.Introduction
This supplement to BMC Proceedings contains the pro-
ceedings of the Genetic Analysis Workshop 19 (GAW19),
which was held August 24–27, 2014 in Vienna, Austria.
The GAWs began in 1982 and are now held every two
years. They provide a forum for statisticians, epidemiolo-
gists, geneticists, bioinformaticians, and other scientists in-
terested in identifying genetic effects on complex diseases
to evaluate and compare novel and existing statistical
methods. Prior to each GAW, topics are chosen based on
suggestions from previous attendees, an existing data set(s)
is selected, and a set of simulated data is devised such that
statistical questions of wide and current interest may be
addressed. These data sets are made available to any re-
searcher who requests them. The same data sets are pro-
vided to all researchers, thus facilitating the discussion and
comparison of methods. After the GAW organizers release
the data sets, researchers analyze the data and prepare a* Correspondence: cengelman@wisc.edu
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the workshop is open to anyone who submits a manu-
script, provides data, or participants in the workshop
organization. More information about the GAWs, in-
cluding details on upcoming meetings, can be found at
http://www.gaworkshop.org.
Genetic Analysis Workshop 19
The family dataset provided for GAW18 was used again
in GAW19 with a few small corrections. New data for
GAW19 included gene expression profiles for the family
data set and a relatively large data set of unrelated indi-
viduals. As in past years, a simulated phenotype data set
was also provided. A brief description of the data sets
follows while a more detailed description can be found
in Blangero et al. [1].
A family data set was provided by the Type 2 Diabetes
Genetic Exploration by Next-Generation Sequencing in
Ethnic Samples [T2D-GENES] Consortium. It included
data from 20 Mexican American families from San
Antonio, Texas, USA, with whole genome sequence in-
formation on 464 individuals. The data set also included
dense single nucleotide polymorphisms (SNPs) on 959le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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genotypes served as the input for the imputation pro-
cedure. Genotype data were provided for odd num-
bered autosomes only, and contained sequence data,
data from a genome-wide Illumina chip containing almost
500 K SNPs, and variant dosages from the Merlin-based
imputation procedure. Gene expression was measured in
a subset of 647 individuals using peripheral blood mono-
nuclear cells (PBMCs) collected at the first examination
and an Illumina chip. The phenotype data were longitu-
dinal measurements of systolic and diastolic blood pres-
sure, sex, age, year of examination, use of antihypertensive
medication and tobacco smoking.
A data set of unrelated individuals was also provided by
the T2D-GENES Consortium. It included 1943 Hispanic
individuals (1021 T2D cases and 922 controls) with
whole-exome sequence data. For this data set, only
samples and variants passing extensive quality control
were provided. As with the family data set, only geno-
type data for odd numbered autosomes were provided.
The phenotypic data included the same basic traits as
the family data set, but were available only at a single
time point.
A simulated data set of 200 phenotype replicates was
provided for both the family and the unrelated data sets.
It was based closely on the real data, with the family
structure (for the family data set), sex, and age taken
directly from the real data. Blood pressure, medication
use, and tobacco smoking were generated anew for each
replicate, using the distributional structure found in the
real data. The simulated values of systolic and diastolic
blood pressure were influenced by over 1000 variants in
over 200 genes. In addition, a normally-distributed trait,
Q1, was simulated that was not influenced by any genetic
variants, but was correlated between family members
(in the family data set). The simulation model is des-
cribed in detail in Blangero et al. [1].
The availability of the GAW19 data was announced by
email in Spring of 2014 to roughly 3500 individuals on
the GAW mailing list. A total of 121 groups requested
GAW19 data and 87 manuscripts were submitted to
GAW organizers prior to the workshop. Submitting au-
thors were asked to select a topic that their research was
most aligned with to facilitate discussion before and
during the workshop. This resulted in 9 discussion/
presentation groups: gene expression (Group 1), ma-
chine learning and data mining (Group 2), variant col-
lapsing approaches (Group 3), family-based approaches
(Group 4), filtering variants and placing informative
priors (Group 5), methods for joint analysis of multiple
phenotypes (Group 6), longitudinal analyses (Group 7),
pathway-based analyses (Group 8), population-based as-
sociation (Group 9). The GAW19 participants included
115 individuals from 16 countries: Australia, Belgium,Canada, China, Egypt, Germany, Hong Kong, Japan, the
Netherlands, Poland, South Korea, Spain, Taiwan, Turkey,
the United Kingdom, and the United States of American.
At GAW19, all groups were led by a person with pre-
vious GAW experience. This person encouraged and
organized the discussion and presentations prior to,
during and after the workshop. Discussions largely
started before the workshop and continued at the work-
shop within group meetings. Each discussion group,
directed by the group leader, was also in charge of pre-
paring a presentation of the issues discussed in the
group and the conclusions drawn. These presentations
were made to all GAW attendees in plenary sessions.
There were also two poster sessions where individual
contributions could be presented.
After the workshop, participants were given just over
two months to revise and resubmit their manuscript for
external peer review by experts in the field. The group
leader typically served as associate editor for the group.
To avoid possible conflicts of interest, articles to which
the group editor contributed were reassigned to other
groups for the peer-review process. Of the 79 manu-
scripts submitted after the workshop, 57 were accepted
for publication in this issue of BMC Proceedings. The
papers are organized according to the group they were in,
preceded by the data description by Blangero et al. [1].
The nine GAW19 group leaders each summarized the
contributions to their group and reviewed the relevant
literature in short manuscripts published in a supple-
ment to BMC Genetics. These 9 summary papers, with
their short reviews of the state of each field, will provide
a useful entry point to researchers working with genomic
data. A summary of these papers follows.
The summary paper on family-based approaches led
by Wijsman [2] provides a brief history of family-based
genetic studies and describes how and why such studies
are enjoying resurgence, partially due to the enrichment
of rare causal genetic variants in such samples. The spe-
cific topics addressed in the contributions varied widely,
from initial study design questions, through quality
control to many aspects of data analysis, and found
numerous benefits associated with studies of carefully
selected related individuals.
Two groups discussed issues around leveraging ex-
ternal information. In the group led by Bailey [3], they
provide an overview of concepts and commonly used
approaches for annotating variants in the genome, as
well as a survey of several principles that are used for
filtering or restricting analysis to only a subset of the
variants. The participants found, in general, that ap-
propriate choices of filters or priors increases power,
not only due to increasing the sizes of true signals, but
also due to reducing the number of tests performed or
the proportion of null tests. The topic of pathway
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Some participants in this group developed new ap-
proaches to pathway analysis, and many used the
simulated data to assess performance. Many in the
group experienced challenges in coping with the di-
mensionality of the data and, due to the imperfections
of the required databases usually required for pathway
analysis, the generalizability of identified pathways was
a concern.
Tests of association between genetic data and pheno-
types were discussed in several of the working groups.
The summary paper from the population-based associ-
ation group led by Bermejo [5] presents various new
methods for testing association, as well as numerous
strategies for coping with the large number of sequence-
identified rare variants and how to decide on validation
strategies. Particular attention was drawn to problems of
estimation and convergence with sparse data, particu-
larly when additional covariates are being explored. A
useful table is provided that contains references for most
key software and methods used by the group. In the
summary paper from the rare variant tests group led by
Santorico [6], an extensive review of methods is pro-
vided followed by carefully placing the 6 contributions
into the resulting analytic framework. The discussion
highlights the need for future extensions and generaliza-
tions of the concept of collapsing tests. Melton led a
group that addressed tests of association with longitudinal
phenotypes [7]. This paper describes recent publications
on longitudinal data, the computational challenges, and
benefits in power and understanding resulting from ap-
propriate longitudinal analyses. Contributors to a group
led by Schillert, developed and compared methods for
analysis of multivariate phenotypes [8]. They frame the
heterogeneous terminology and goals that are in use for
analysis and interpretation of multivariate phenotypes.
Although the approaches used by participants were di-
verse, all showed potential, both in terms of power and
computational feasibility.
Cantor led the group studying methods for analysis of
gene expression data [9]. The paper provides a quick yet
broad overview of the ways in which gene expression
data have typically been analyzed since high-throughput
arrays became accessible, as well as important design
and analysis issues. One of the key issues addressed by
most group members was how to utilize gene expression
measures taken from related individuals. Finally, a group
on machine learning and data mining led by König [10]
also addressed questions around data integration. Their
paper is organized around key messages such as the
benefits of integrating data of different types and the
computational limitations. For each of the messages, a
brief introduction presents some key references prior to
introducing the work of the group.Overall GAW19 generated many interesting discus-
sions and some conclusions concerning the analysis of
human sequence and gene expression data. These dis-
cussions also highlighted areas in which further metho-
dological development is needed.Acknowledgements
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